Protein 4.1R affects photodynamic therapy for B16 melanoma by regulating the transport of 5-aminolevulinic acid

Cytoskeleton protein 4.1R suppresses murine keratinocyte cell hyperproliferation via activating the Akt/ERK pathway in an EGFR-dependent manner

(2019) Lixiang Chen et al.   EXPERIMENTAL CELL RESEARCH

Epithelial-specific isoforms of protein 4.1R promote adherens junction assembly in maturing epithelia

(2019) Shu-Ching Huang et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

European Dermatology Forum guidelines on topical photodynamic therapy 2019 Part 2: emerging indications – field cancerization, photorejuvenation and inflammatory/infective dermatoses

(2019) C.A. Morton et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Immune consequences induced by photodynamic therapy in non-melanoma skin cancers: a review

(2018) Xin Yu et al.   ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH

Resistance of oral cancer cells to 5-ALA-mediated photodynamic therapy

(2018) Flávia Cristina P. Rosin et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

5-ALA in the management of malignant glioma

(2018) Herbert Stepp et al.   LASERS IN SURGERY AND MEDICINE

Biologics in patients with skin diseases

(2017) Mylène S. Veilleux et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Comparative investigation of the effects of specific antigen-sensitized DC-CIK and DC-CTL cells against B16 melanoma tumor cells

(2017) Peng-Tao Ren et al.   Molecular Medicine Reports

Protein 4.1R is Involved in the Transport of 5-Aminolevulinic Acid by Interaction with GATs in MEF Cells

(2017) Shuwei Ning et al.   PHOTOCHEMISTRY AND PHOTOBIOLOGY

Oncologic Photodynamic Therapy: Basic Principles, Current Clinical Status and Future Directions

(2017) Demian van Straten et al.   Cancers

5-Aminolevulinic acid regulates the inflammatory response and alloimmune reaction

(2016) Masayuki Fujino et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Targeting Antitumor Immune Response for Enhancing the Efficacy of Photodynamic Therapy of Cancer: Recent Advances and Future Perspectives

(2016) Yamin Yang et al.   Oxidative Medicine and Cellular Longevity

Photodynamic Therapy for Non-Melanoma Skin Cancers

(2016) Diana Cohen et al.   Cancers

Immunological aspects of antitumor photodynamic therapy outcome

(2015) Małgorzata Wachowska et al.   Central European Journal of Immunology

Effective Two-Photon Excited Photodynamic Therapy of Xenograft Tumors Sensitized by Water-Soluble Bis(arylidene)cycloalkanone Photosensitizers

(2015) Qianli Zou et al.   JOURNAL OF MEDICINAL CHEMISTRY

Cancer treatment and survivorship statistics, 2014

(2014) Carol E. DeSantis et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Photodynamic Therapy of Murine Mastocytoma Induces Specific Immune Responses against the Cancer/Testis Antigen P1A

(2013) P. Mroz et al.   CANCER RESEARCH

Homology Modeling of Human γ-Butyric Acid Transporters and the Binding of Pro-Drugs 5-Aminolevulinic Acid and Methyl Aminolevulinic Acid Used in Photodynamic Therapy

(2013) Yan Baglo et al.   PLoS One

Cytoskeletal protein 4.1R negatively regulates T-cell activation by inhibiting the phosphorylation of LAT

(2009) Q. Kang et al.   BLOOD

Protein 4.1R-dependent multiprotein complex: New insights into the structural organization of the red blood cell membrane

(2008) M. Salomao et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Association between myeloid malignancies and acquired deficit in protein 4.1R: A retrospective analysis of six patients

(2007) Cécile Alanio-Bréchot et al.   AMERICAN JOURNAL OF HEMATOLOGY